BriaCell Therapeutics (BCTX) vs GridAI Technologies (GRDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GridAI Technologies (GRDX) has outperformed BriaCell Therapeutics (BCTX) over the past year, gaining 0.0% versus a loss of 68.3%. Over five years, BCTX leads with a -95.1% price change compared with -100.0% for GRDX. BriaCell Therapeutics is the larger company by market cap ($34.2 million vs $32.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCTX | GRDX |
|---|---|---|
| Share price | $3.94 | $4.53 |
| Market cap | $34.23M | $32.27M |
| 1-day change | -1.63% | +9.84% |
| YTD return | -43.74% | -11.59% |
| 1-year return | -68.33% | 0.00% |
| 5-year return | -95.12% | -99.99% |
| EPS (TTM) | $-0.92 | $-5.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.68 | $6.93 |
| 52-week low | $2.60 | $1.87 |
| Distance from 52-week high | -73.19% | -34.69% |
| Average volume | 280.62K | 101.84K |
| Shares outstanding | 8.70M | 7.13M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed BCTX by 68.3 percentage points over the past year.
BCTX vs GRDX FAQ
Which is bigger, BriaCell Therapeutics or GridAI Technologies?
BriaCell Therapeutics (BCTX) is larger, with a market capitalization of $34.23M compared with $32.27M for GridAI Technologies (GRDX).
Which stock has performed better over the past year, BCTX or GRDX?
GRDX returned 0.00% over the past 12 months, compared with -68.33% for BCTX (price return, excluding dividends). Past performance does not predict future results.
Are BriaCell Therapeutics and GridAI Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.